135 related articles for article (PubMed ID: 14707397)
1. Does ursodeoxycholic acid change the proliferation of the colorectal mucosa?. A randomized, placebo-controlled study.
Ochsenkühn T; Marsteller I; Hay U; Diebold J; Paumgartner G; Göke B; Sackmann M
Digestion; 2003; 68(4):209-16. PubMed ID: 14707397
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study.
Serfaty L; De Leusse A; Rosmorduc O; Desaint B; Flejou JF; Chazouilleres O; Poupon RE; Poupon R
Hepatology; 2003 Jul; 38(1):203-9. PubMed ID: 12830003
[TBL] [Abstract][Full Text] [Related]
3. Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers.
van Gorkom BA; van der Meer R; Boersma-van Ek W; Termont DS; de Vries EG; Kleibeuker JH
Scand J Gastroenterol; 2002 Aug; 37(8):965-71. PubMed ID: 12229974
[TBL] [Abstract][Full Text] [Related]
4. Colonic mucosal proliferation is related to serum deoxycholic acid levels.
Ochsenkühn T; Bayerdörffer E; Meining A; Schinkel M; Thiede C; Nüssler V; Sackmann M; Hatz R; Neubauer A; Paumgartner G
Cancer; 1999 Apr; 85(8):1664-9. PubMed ID: 10223558
[TBL] [Abstract][Full Text] [Related]
5. Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled clinical trial.
Bostick RM; Fosdick L; Wood JR; Grambsch P; Grandits GA; Lillemoe TJ; Louis TA; Potter JD
J Natl Cancer Inst; 1995 Sep; 87(17):1307-15. PubMed ID: 7658483
[TBL] [Abstract][Full Text] [Related]
6. Effect of vitamin A, C, and E supplementation on rectal cell proliferation in patients with colorectal adenomas.
Paganelli GM; Biasco G; Brandi G; Santucci R; Gizzi G; Villani V; Cianci M; Miglioli M; Barbara L
J Natl Cancer Inst; 1992 Jan; 84(1):47-51. PubMed ID: 1738173
[TBL] [Abstract][Full Text] [Related]
7. Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.
Thompson PA; Wertheim BC; Roe DJ; Ashbeck EL; Jacobs ET; Lance P; Martínez ME; Alberts DS
Cancer Prev Res (Phila); 2009 Dec; 2(12):1023-30. PubMed ID: 19952360
[TBL] [Abstract][Full Text] [Related]
8. Prevention of colitis-associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid.
Loddenkemper C; Keller S; Hanski ML; Cao M; Jahreis G; Stein H; Zeitz M; Hanski C
Int J Cancer; 2006 Jun; 118(11):2750-7. PubMed ID: 16385573
[TBL] [Abstract][Full Text] [Related]
9. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.
Alberts DS; Martínez ME; Hess LM; Einspahr JG; Green SB; Bhattacharyya AK; Guillen J; Krutzsch M; Batta AK; Salen G; Fales L; Koonce K; Parish D; Clouser M; Roe D; Lance P;
J Natl Cancer Inst; 2005 Jun; 97(11):846-53. PubMed ID: 15928305
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.
Ward JBJ; Lajczak NK; Kelly OB; O'Dwyer AM; Giddam AK; Ní Gabhann J; Franco P; Tambuwala MM; Jefferies CA; Keely S; Roda A; Keely SJ
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G550-G558. PubMed ID: 28360029
[No Abstract] [Full Text] [Related]
12. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
[TBL] [Abstract][Full Text] [Related]
13. Folic acid mediated attenuation of loss of heterozygosity of DCC tumor suppressor gene in the colonic mucosa of patients with colorectal adenomas.
Nagothu KK; Jaszewski R; Moragoda L; Rishi AK; Finkenauer R; Tobi M; Naumoff JA; Dhar R; Ehrinpreis M; Kucuk O; Majumdar AP
Cancer Detect Prev; 2003; 27(4):297-304. PubMed ID: 12893078
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of colorectal cancer with ursodeoxycholic acid: pro.
Serfaty L
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S53-60. PubMed ID: 23141895
[TBL] [Abstract][Full Text] [Related]
15. The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps.
Alberts DS; Einspahr J; Ritenbaugh C; Aickin M; Rees-McGee S; Atwood J; Emerson S; Mason-Liddil N; Bettinger L; Patel J; Bellapravalu S; Ramanujam PS; Phelps J; Clark L
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):161-9. PubMed ID: 9138658
[TBL] [Abstract][Full Text] [Related]
16. Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas.
Courtney ED; Matthews S; Finlayson C; Di Pierro D; Belluzzi A; Roda E; Kang JY; Leicester RJ
Int J Colorectal Dis; 2007 Jul; 22(7):765-76. PubMed ID: 17216221
[TBL] [Abstract][Full Text] [Related]
17. Effects of deoxycholic acid and butyrate on mucosal prostaglandin E2 release and cell proliferation in the human sigmoid colon.
Bartram HP; Scheppach W; Englert S; Dusel G; Richter A; Richter F; Kasper H
JPEN J Parenter Enteral Nutr; 1995; 19(3):182-6. PubMed ID: 8551644
[TBL] [Abstract][Full Text] [Related]
18. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia.
Lindström L; Boberg KM; Wikman O; Friis-Liby I; Hultcrantz R; Prytz H; Sandberg-Gertzén H; Sangfelt P; Rydning A; Folvik G; Gangsøy-Kristiansen M; Danielsson A; Bergquist A
Aliment Pharmacol Ther; 2012 Feb; 35(4):451-7. PubMed ID: 22221173
[TBL] [Abstract][Full Text] [Related]
19. Effect of butyrate enemas on gene expression profiles and endoscopic/histopathological scores of diverted colorectal mucosa: A randomized trial.
Luceri C; Femia AP; Fazi M; Di Martino C; Zolfanelli F; Dolara P; Tonelli F
Dig Liver Dis; 2016 Jan; 48(1):27-33. PubMed ID: 26607831
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives.
Baisini O; Benini F; Petraglia F; Kuhnz W; Scalia S; Marschall HU; Brunetti G; Tauschel HD; Lanzini A
Eur J Clin Pharmacol; 2004 Sep; 60(7):481-7. PubMed ID: 15289960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
